ADMA Biologics Inc (ADMA)

Current ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total current assets	US$ in thousands	331,410	257,013	270,402	208,729	153,741
Total current liabilities	US$ in thousands	55,542	49,806	39,267	30,378	19,947
Current ratio		5.97	5.16	6.89	6.87	7.71

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $331,410K ÷ $55,542K
= 5.97

The current ratio of ADMA Biologics Inc has been consistently high over the past few years, indicating strong short-term liquidity. The ratio stood at 7.71 as of December 31, 2020, and although it slightly decreased to 6.87 by December 31, 2021, it remained relatively stable around 6.89 by December 31, 2022. However, there was a noticeable drop to 5.16 by December 31, 2023, which indicates a potential decline in short-term liquidity. The ratio improved slightly to 5.97 by December 31, 2024, but it remains below the levels seen in the earlier years. Overall, while the company has maintained a relatively healthy current ratio, management may need to closely monitor it to ensure sufficient liquidity to meet short-term obligations.